Search

everythinglearnresearchcommunity

for

Search:↓

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

The document concludes that improving patient safety and quality is increasingly important in dermatology.

Using camphorated and mentholated chlorophenol in dental treatments can lead to severe gastrointestinal issues and hair and nail loss.

COVID-19 is linked to temporary hair loss, especially in women.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Certain fungi protect skin health, but changes can allow harmful fungi to cause serious infections, needing more research for treatment and control.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Patients with mandible reconstruction had better quality of life and function than those with soft-tissue reconstruction.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The niche environment controls stem cell behavior and plasticity, which is important for tissue health and repair.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

PLD is an effective and safer alternative for treating breast cancer.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.